8 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27997879	15	Design and synthesis of emodin derivatives as novel inhibitors of ATP-citrate lyase.	Harvard Medical School
21726077	51	The lipogenesis pathway as a cancer target.	Wayne State University
1479587	4	ATP-citrate lyase as a target for hypolipidemic intervention. Sulfoximine and 3-hydroxy-beta-lactam containing analogues of citric acid as potential tight-binding inhibitors.	Smithkline Beecham Pharmaceuticals
9733484	39	ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivo.	Smithkline Beecham Pharmaceuticals
8784456	55	ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzyme.	Smithkline Beecham Pharmaceuticals
7853346	13	Synthesis of novel thiol-containing citric acid analogues. Kinetic evaluation of these and other potential active-site-directed and mechanism-based inhibitors of ATP citrate lyase.	Smithkline Beecham Pharmaceuticals
30195238	26	ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism.	University of Pisa
2788743	6	Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta',beta'-tetrasubstituted, long-chain dioic acids.	Hebrew University